TNON | Tenon Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.41 - 3.72
52 Week Range	2.8000 - 37.60
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	428,183
Average Volume	2,531,239
Shares Outstanding	510,221
Market Cap	1,750,058
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2022-04-27

Valuation
Profitability
Growth
Health
P/E Ratio	-0.13
Forward P/E Ratio	N/A
EPS	-26.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	21
Country	USA
Website	TNON

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

TNON's peers: BBLG, MODD, BMRA, XTNT, ECOR, ICCM, IRIX, MOVE, NMTC, NSPR, NSYS, NUWE, NVNO, OWLT, RSLS, TIVC, STSSW, AIMD, SSKN, NPCE, INVO, MOTS, ASAPF, DYNT, AZYO, SGHT, HSCS

*Chart delayed

Analyzing fundamentals for TNON we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see TNON Fundamentals page.

Watching at TNON technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on TNON Technicals page.